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Fel ine haemoplasma species
Why Candidatus?
The assigning of a ‘Candidatus’ status to three of the feline haemoplasmas reflects their provisional classification in
bacterial nomenclature. Characterisation (especially phenotypic) of these species has not been possible due to them
being uncultivable in vitro. M haemofelis was not assigned this status, despite also being uncultivable in vitro, because 
it represents the new name for a species that previously existed (H felis), and bacterial nomenclature rules state that
species cannot be assigned a ‘Candidatus’ status retrospectively.
✜ Mycoplasma haemofelis Often associated with haemolytic
anaemia during acute infection. 
✜ ‘Candidatus Mycoplasma haemominutum’ May result 
in a fall in red blood cell parameters, but anaemia is not normally
induced unless concurrent disease is present.
✜ ‘Candidatus Mycoplasma turicensis’ May result in a fall in
red blood cell parameters, but anaemia is not normally induced
unless concurrent disease is present.
✜ ‘Candidatus Mycoplasma haematoparvum-like’ No data 
on pathogenesis is currently available.
Mycoplasma haemofelis 
While acute experimental M haemofelis infec-
tion often results in haemolytic anaemia,
prevalence studies in naturally infected cats
have not consistently demonstrated an associ-
ation between anaemia and M haemofelis infec-
tion. Differing results could arise due to 
different populations of cats being sampled 
or different isolates of M haemofelis being
involved in these studies, and/or reflect the
acute versus chronic nature of M haemofelis
infection (it has been hypothesised that acute
M haemofelis infection is more likely to be asso-
ciated with anaemia than chronic infection).4
Nevertheless, of the known feline haemoplas-
ma species, M haemofelis is regarded as being
the most pathogenic and the one most likely
to be associated with clinical disease.
‘Candidatus M haemominutum’ 
Experimental ‘Candidatus M haemominutum’
infection rarely results in significant clinical
signs and anaemia is not usually induced,
although a fall in red blood cell parameters can
occur.3,5 Significant anaemia may arise follow-
ing ‘Candidatus M haemominutum’ infection in
retrovirus-infected cats, particularly those with
feline leukaemia virus (FeLV) infection, in
which ‘Candidatus M haemominutum’ may
also play a role in inducing bone marrow disor-
ders.6 Studies in naturally infected cats have
also suggested an influence on bone marrow
disorders, with a blunted erythrocyte regenera-
tive response having been recorded in cats
infected with ‘Candidatus M haemominutum’.1
Studies of naturally infected cats have usual-
ly failed to demonstrate associations between
anaemia and ‘Candidatus M haemominutum’,
although ‘Candidatus M haemominutum’-
FIG 2 Graph showing
representative mean
haemoglobin values for
three groups of cats infected
with either M haemofelis,
‘Candidatus M
haemominutum’ or
‘Candidatus M turicensis’.
The grey shaded area
represents the reference
range for haemoglobin 
(8–15 g/dl). As can be seen, 
only the cats infected with 
M haemofelis became
anaemic, with the lowest
haemoglobin values
recorded between 2 and 3
weeks following infection.
By contrast, cats infected
with ‘Candidatus M
haemominutum’ and
‘Candidatus M turicensis’
showed only a slight fall in
haemoglobin values during
the first 2–3 weeks of
infection. Graph adapted from
data collected for a previously
published study3
Are the feline haemoplasmas
pathogenic?
The feline haemoplasma species that are 
currently recognised vary in pathogenicity, 
with some isolates consistently inducing
haemolytic anaemia whereas others result 
in few noticeable clinical signs (Fig 2).
However, it is not only the infecting species
or isolate that influences clinical signs – dura-
tion of infection and host factors, such as the
presence of concurrent disease or retrovirus
status, can also play a part. Age, too, may be
important in that it has been suggested that
younger cats are more susceptible to clinical
haemoplasmosis.2,3 Other factors such as
infecting organism dose or route of infection
may also impact on outcome.
The influence of many of these factors has
not yet been fully investigated or charac-
terised. Unfortunately, therefore, generalised
predictions of disease outcome following
natural haemoplasma infection in an indi-
vidual cat cannot be made. These factors
must be considered when trying to 
determine the significance of haemoplasma
infection in an individual cat.
Unfortunately, generalised predictions of disease
outcome following natural haemoplasma infection
in an individual cat cannot be made.
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associated anaemia has been reported in a cat
undergoing chemotherapy for lymphoma and 
a number of cases of apparent primary
‘Candidatus M haemominutum’-associated
anaemia have been described.7,8 However, one
US study found that ‘Candidatus M haemomin-
utum’-infected cats were actually less likely to
be anaemic than haemoplasma-negative cats.1
The pathogenicity of ‘Candidatus M
haemominutum’ infection is therefore difficult to
summarise. It is likely that different ‘Candidatus
M haemominutum’ isolates have varying patho-
genicity and that the underlying health status of
the cat plays a role in the outcome of infection.
‘Candidatus M turicensis’ 
‘Candidatus M turicensis’ was first described in
2005,9 where it was associated with haemolytic
anaemia, although colleagues and I have
reported a fall in red blood cell parameters
without induction of anaemia with ‘Candidatus
M turicensis’ infection.3 In naturally infected
cats, only those co-infected with ‘Candidatus M
haemominutum’ or M haemofelis, and not
‘Candidatus M turicensis’-only infected cats,
exhibited significantly lower packed cell 
volumes (PCVs) compared with haemoplas-
ma-uninfected cats.10 A significant number of
‘Candidatus M turicensis’-infected cats have
concurrent diseases, such as neoplasia or feline
immunodeficiency virus (FIV) infection,4
suggesting that co-factors and immunosup-
pression may be important in the pathogenesis
of disease caused by this agent.
How common are the feline
haemoplasmas?
In most prevalence studies ‘Candidatus M
haemo minutum’ has been the most common
haemoplasma found, with fewer numbers of
‘Candidatus M turicensis’ and M haemofelis
detected. However, high prevalences of the 
latter two species have occasionally been report-
ed, such as in a South African study (‘Candidatus
M turicensis’)11 and a Canadian study (M
haemofelis).12 The only study that has document-
ed ‘Candidatus M haematoparvum-like’ infec-
tion in cats was from the USA, and only a low
prevalence (0.7%) of infection was found.1
Interestingly, recent prevalence studies from the
same group,2 and a group in Italy,13 failed to find
any evidence of ‘Candidatus M haematoparvum-
like’ infection in cats. The ranges of prevalence
of feline haemoplasma species reported to date
are summarised in Table 1.
How are the feline
haemoplasmas transmitted?
Social contact
Studies evaluating risk factors for haemoplas-
ma infection have generally found that older
male cats, with outdoor access, are more likely
to be infected. The increased prevalence in male
cats, together with reports that cat bite abscess-
es and outdoor roaming are risk factors, have
led to the suggestion that horizontal trans -
mission may occur via fighting. In line with this
both ‘Candidatus M haemominutum’ and
‘Candidatus M turicensis’ DNA has been found
in the saliva of infected cats.4,14 However, recent
studies failed to show the successful transmis-
sion of ‘Candidatus M turicensis’ infection
between cats by the oral or subcutaneous 
inoculation of ‘Candidatus M turicensis’-infected
saliva, even though the same dose of
‘Candidatus M turicensis’ in blood led to 
successful transmission when inoculated 
subcutaneously.15
More work in this field is required but it
seems probable that haemoplasma transmis-
sion via social contact is unlikely but that
aggressive interaction (eg, cat bites) may
result in transmission if the recipient cat is
exposed to infectious blood rather than just
saliva.
Arthropod vector  
The cat flea Ctenocephalides felis has been incrim-
inated in the transmission of haemoplasmosis
between cats although only transient trans -
mission of M haemofelis to a cat via the
haematophagous activity of Ct felis was demon-
strated.16 Studies have found evidence of feline
haemoplasma infection in fleas collected from
cats,12,17–19 and in some ticks.20,21 Additionally, 
in one US study,22 community-sourced cats that
were housed indoors without a history of ticks
or fleas were less likely to have haemoplasma
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Haemoplasma species Reported prevalence*
‘Candidatus M haemominutum’ 10–32.1%
M haemofelis 0.4–46.6%
‘Candidatus M turicensis’ 0.4–26%
‘Candidatus M haematoparvum-like’ 0–0.7%
*From various reference sources1,2,4,11–13
Reported prevalences for the feline haemoplasmasTABLE 1
It seems probable that haemoplasma transmission via social contact is unlikely 
but that aggressive interaction (eg, cat bites) may result in transmission 
if the recipient cat is exposed to infectious blood rather than just saliva.
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infections than those that had access outdoors or
had a history of ticks or fleas. The clustered geo-
graphic distribution of haemoplasma infection
in US and Swiss studies is also supportive of
arthropod-borne transmission.1,4 However,
despite this supportive evidence, direct evi-
dence for the role of vectors in natural/field
haemoplasma transmission between cats is lack-
ing. We have certainly seen haemoplasma trans-
mission between cats in the absence of vectors
so, even if fleas or ticks have the ability to act as
vectors for haemoplasmosis in cats, other means
of haemoplasma transmission must exist.
Blood transfusions
Transmission via contaminated blood transfu-
sions has been reported,4 and the use of freshly
collected blood from a haemoplasma-infected
blood donor for transfusion would very likely
result in transmission of infection to the recipient
cat. The risk of haemoplasma transmission when
using stored blood for transfusions depends on
the viability of haemoplasmas in stored blood.
One study evaluated this by looking at the
survival of haemoplasma organisms in blood
collected into citrate-phosphate-dextrose-ade-
nine (CPDA) anticoagulant.23 Haemoplasma
survival was assessed by the ability to transmit
M haemofelis or ‘Candidatus M haemominutum’
infection to naive cats via the intravenous
inoculation of infected blood that had been
stored in CPDA anticoagulant at 4°C for 1 h, 
1 week or 1 month. M haemofelis was only suc-
cessfully transmitted to the naive cat given the
blood that had been stored for 1 h; there was
evidence of subsequent in vivo amplification
of M haemofelis organisms in the recipient cat’s
blood, as organism numbers increased during
the 3-week post-inoculation monitoring 
period. Some evidence for ‘Candidatus M
haemominutum’ transmission was also found
using the blood stored for 1 h, although organ-
ism numbers in the recipient naive cat did 
not increase post-inoculation. ‘Candidatus M
haemominutum’-infected blood that had been
stored for 1 week resulted in a single positive
polymerase chain reaction (PCR) result in the
naive cat, in only one of two PCR assays used,
so successful persistent transmission was not
seen. But this work suggested that ‘Candidatus
M haemominutum’ may be able to survive for
up to a week in CPDA anticoagulant.
Interestingly, and in contrast to these
results, experimental studies at the University
of Bristol have found that the viability of
haemoplasma organisms in blood collected
into EDTA or heparin anticoagulants is very
short-lived (less than 1 h), as inoculations with
blood stored for longer periods have failed.
Survival of haemoplasma organisms outside
of the host therefore needs more investigation.
This is hard to research because of the current
absence of a haemoplasma in vitro culture
system, meaning that only in vivo inoculations
can prove organism viability.
Other modes of transmission
Other possible modes of haemoplasma trans-
mission include vertical transmission from
queen to kittens during pregnancy, at birth or
via lactation. Although not reported, transmis-
sion may also be possible via the use of multi-
use vials between cats, or the inappropriate
use of the same equipment (eg, surgical instru-
ments) on different cats without adequate
cleaning/sterilisation, particularly if blood
contamination was significant and only a short
time elapsed between consecutive procedures.
How do haemoplasmas induce
anaemia?
Most of the haemolysis associated with haemo-
plasma infection is believed to be extravascular
in nature, occurring in the spleen and liver
especially, but also in the lungs and bone mar-
row. Intravascular haemolysis has also been
reported, as has increased osmotic fragility of
haemoplasma-infected red blood cells.9
Positive Coombs’ tests and autoagglutina-
tion, indicating the presence of erythrocyte-
bound antibodies, have been demonstrated in
anaemic M haemofelis-infected cats.3 Such 
erythrocyte-bound antibodies could be respon-
sible for immune-mediated destruction of red
blood cells. In a study describing the nature of
positive Coombs’ tests in M haemofelis-infected
cats,3 erythrocyte-bound antibodies reactive at
4°C (both IgM and IgG) appeared a few days
earlier than those reactive at 37°C (primarily
IgG). Despite this, in most cats the erythrocyte-
bound antibodies appeared only after anaemia
had started to develop. The absence of erythro-
cyte-bound antibodies at the onset of develop-
ment of anaemia could reflect a problem with
the sensitivity of detection of erythrocyte-
bound antibodies; however, an alternative
explanation is that erythrocyte-bound antibod-
ies appear as a result of haemoplasma-induced
haemolysis, rather than initiating the haemoly-
sis. Indeed we have documented disappear-
ance of these antibodies with antibiotic and
supportive treatment alone, without the need
for specific glucocorticoid treatment, question-
ing the key role of such antibodies in haemo-
plasma-induced anaemia.
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Even if fleas or ticks have the ability to act as vectors for haemoplasmosis 
in cats, other means of transmission must exist.
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What are the clinical signs
of haemoplasmosis?
As mentioned, the clinical signs
of haemoplasma infection
depend on factors such as 
the haemoplasma species
involved, stage of infection
and whether concurrent dis-
eases or infections are present.
Common signs exhibited by
acutely ill cats include pallor
(Fig 3), lethargy, anorexia, weight
loss, depression and dehydration.
Intermittent pyrexia is often seen,
particularly in the acute stages of 
disease, as is splenomegaly, which may
reflect extramedullary haematopoiesis.
Jaundice is uncommon unless severe acute
haemolysis occurs.  
How is haemoplasmosis
diagnosed?
Blood smear
examination
Diagnosis of haemoplas-
ma infection used to rely
on cytological examination
of a Romanowsky-stained
blood smear, with organ-
isms appearing on the 
surface of erythrocytes as
rounded bodies singly (Fig
4), in pairs, or occasionally
in chains. Diff-Quik or 
filtered Giemsa stains can
be used. However, cyto-
logical diagnosis has poor 
sensitivity and specificity.
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FIG 3 Pale mucous membranes of an anaemic cat with acute
M haemofelis infection. Clinical jaundice, due to acute severe
haemolysis, is only occasionally seen in cats with
haemoplasmosis
Haematology
When anaemia is induced by haemoplasma infection, it is typically regenerative (or pre-regenerative
if sampling occurs very soon after the onset of anaemia), macrocytic, and normo- or hypochromic.
However, significant reticulocytosis is not always present, even when pre-regenerative cases are
excluded, possibly due to concurrent retroviral infections or other disease processes. Release of
sequestered erythrocytes from the spleen may also result in a marked rise in red blood cell count
without an accompanying reticulocytosis. As mentioned on page 372, positive Coombs’ tests and
autoagglutination may also occur.
Biochemistry
Serum biochemistry may reveal hyperproteinaemia due to dehydration or an acute phase response,
and increased liver enzyme levels may arise from hepatic hypoxic damage. Hyperbilirubinaemia can
result from the haemolysis.3
Laboratory features of  pathogenic haemoplasmosis
Sensitivity is a particular issue, with
figures of only 0–37.5% reported in
various studies.25–27 Specificity is
usually higher, with values of
84–98% reported,25,26 although
these figures are based on board-
certified clinical pathologists
examining and interpreting
blood smears.
If reliable blood smear inter-
pretation is available, the cytolog-
ical detection of organisms during
acute infection can be useful as a
bench-side and immediate diagnos-
tic test. However, in the author’s 
experience, many cases diagnosed as
being haemoplasma-infected on the basis
of blood smear interpretation in practice have
been false positives, with stain precipitate,
Howell-Jolly bodies and artefacts due to slow
blood smear drying being the most common
reasons for error. Additionally cytology cannot
differentiate between haemoplasma species.
FIG 4 Romanowsky-stained blood smear from a cat infected
with ‘Candidatus M haemominutum’. Organisms are seen as
dark purple-blue dots on the surface of red blood cells.
Although the organisms are clearly visible here, cytological
confirmation of haemoplasma infection is very insensitive
Carrier cats
Cats that recover from haemoplasma infection may remain
chronically infected. In our experience, long-term carrier 
status appears to be especially common following ‘Candidatus
M haemominutum’ infection, although suspected clearance of
this infection has been reported with and without antibiotic 
treatment.4 M haemofelis-infected cats may spontaneously clear
infection from peripheral blood after infection without antibiotic
treatment, and such clearance has also been reported with
‘Candidatus M turicensis’ infection. It is clear that variation
exists in the long-term host–organism interaction, making
long-term predictions of outcome impossible. In any
haemoplasma-infected carrier cat the potential for reac-
tivation of infection exists, which can result in clini-
cal disease,24 although this seems to be quite
rare once haemoplasma infection has
become established beyond
acute infection. 
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Polymerase chain reaction
Polymerase chain reaction amplifies
specific lengths of DNA so that
potentially tiny amounts of DNA 
in samples are detectable. When
designed properly, PCR has the
potential to be extremely sensitive
and specific for haemoplasma diag-
nosis.28 Sen sitivity and specificity
should always be available from labo-
ratories offering PCR assays commer-
cially, so that their reliability can be eval-
uated objectively. Additionally laboratories
undertaking PCR should always use appro-
priate negative and positive controls, as well
as internal amplification controls, to monitor
for contamination or problems with the assay.   
Polymerase chain reaction is known to be
more sensitive than cytology for haemoplasma
detection.24,25,27,29–31 All feline haemoplasma
PCR assays described so far are based on
amplification of segments of the haemoplasma
16S rRNA gene. Most conventional, non-
quantitative PCR (cPCR) assays detect and dis-
tinguish both ‘Candidatus M haemominutum’
and M haemofelis,29,30,32 but do not amplify 
or differentiate ‘Candidatus M turicensis’,
although a recent study has described a sepa-
rate specific cPCR for ‘Candidatus M turicen-
sis’.33 Real-time quantitative PCR (qPCR)
assays34 have an additional level of specificity
compared with cPCR, through the use of 
fluorogenic probes in addition to primers.
Quantitative PCR assays exist that amplify
and differentiate all three feline haemoplasma
species. Additionally some available assays
are duplexed to concurrently amplify an inter-
nal control, such as the feline 28S rRNA gene,
to ensure that any negative PCR results have
not arisen due to problems with DNA extrac-
tion, quality or PCR inhibition.34 Quantitative
PCRs also allow quantification of the amount
of haemoplasma DNA present in the patient’s
blood, which may help determine the signifi-
cance of haemoplasma infection and/or
allow monitoring of the response to
treatment (see later). Quantitative
PCR furthermore is a lot more rapid
than cPCR and has a reduced risk 
of contamination compared with
cPCR, since the tubes containing the
PCR product are never opened 
during analysis.  
What is the typical course 
of haemoplasma infection?
Quantitative PCR assays have allowed quan-
tification of haemoplasma copy (organism)
numbers in the blood of infected cats.3–5,35,36
Previously, accurate quantification of haemo-
plasma infection in vivo had not been possible
due to the uncultivable status of the haemo-
plasmas. Cats experimentally infected with
haemoplasma species initially show a rapid
increase in copy numbers, with peak numbers
typically being reached around 2–4 weeks
after infection (Fig 5). However, M haemofelis
copy numbers can fluctuate greatly, even with-
in the initial post-infection period. Some M
haemofelis-infected cats continue to show very
large changes in M haemofelis copy numbers
for several months following experimental
infection (Fig 6), which should be borne in
mind when interpreting qPCR results. These
fluctuations can be as large and as rapid as 
a four-log difference over 2 or 3 days, or a
seven-log difference over 12 days. In 
contrast, ‘Candidatus M haemominutum’- and
‘Candidatus M turicensis’-infected cats show
less or little fluctuation in copy numbers.
The reason for the marked fluctuations in
blood M haemofelis copy numbers over time
seen in some cats has been a focus of recent
research. Possible causes include sequestra-
tion and subsequent release of organisms
from organs such as the spleen, liver or
lungs,37 cyclical antigenic variation used by
FIG 5 Graph showing representative mean haemoplasma
copy numbers over time for three groups of cats infected 
with either M haemofelis, ‘Candidatus M haemominutum’ or
‘Candidatus M turicensis’. Haemoplasma copy numbers were
measured by qPCR and the values shown represent those
present per 5 μl of blood, assuming perfectly efficient DNA
extraction and PCR. As can be seen, cats infected with
‘Candidatus M turicensis’ have significantly lower blood copy
numbers than cats infected with the other two species, and
the ‘Candidatus M turicensis’-infected cats in this study
become qPCR negative as early as 45 days after infection.
Cats infected with M haemofelis and ‘Candidatus M
turicensis’ tend to reach peak copy numbers around 2 weeks
following infection, whereas copy numbers in cats infected
with ‘Candidatus M haemominutum’ tend to peak a little later,
at around 4 weeks following infection. Since the lines shown
in this graph represent the mean haemoplasma copy numbers
recorded for each group of cats, the marked fluctuation in
copy numbers often seen in individual M haemofelis-infected
cats is not visible here, but is represented in Fig 6. Graph
adapted from data collected for a previously published study3
Sampling for haemoplasma PCR
Only a small amount of blood is required for PCR.
Most diagnostic laboratories request 1 ml of anti-
coagulated blood, although in reality PCR is usually
performed using DNA extracted from smaller vol-
umes of blood (0.1 or 0.2 ml). EDTA-anticoagulated
blood is usually required since heparin inhibits
PCR. DNA is quite stable within blood samples
so rapid or cold shipping of samples is not
required. Blood sampling for PCR should
preferably be undertaken before a
cat undergoes any antibiotic
treatment.
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some haemotropic and mycoplas-
mal species to evade the host
immune response,38,39 or the
rapid removal and subsequent
rapid multiplication of organ-
isms remaining in the blood.
One recent study failed to
show any evidence of tissue
sequestration of M haemofelis
organisms,36 so this is
unlikely to be the cause. 
The marked increase in M
haemofelis copy numbers seen
in the blood immediately after
initial infection confirms that
rapid multiplication of organisms
is possible in infected cats, so it
seems likely that such rapid multipli-
cation (rather than organism release from
sequestration sites) may be responsible for the
marked rapid increases in M haemofelis
copy numbers seen in infected cats during 
M haemofelis cycling. The marked rapid
decreases in M haemofelis copy numbers could
arise due to rapid effective clearance of organ-
isms from the blood and their subsequent
destruction.   
Haemoplasma infection has been detected
as early as one day post-infection by qPCR in
the blood of experimental cats. Following
recovery from acute clinical disease, cats can
remain chronically infected. In some cases this
chronic carrier status is lifelong, whereas in
others anti biotic therapy or spontaneous elim-
ination of the organism results in apparent
clearance of infection. Cats usually remain
Up to 10% of healthy cats at any time are infected with feline haemoplasmas,
emphasising that a positive PCR result does not always 
correlate with the presence of clinical haemoplasmal disease. 
PCR positive during chronic carrier
status. Up to 10% of healthy cats
at any time are infected with
feline haemoplasmas,12,25
emphasising that a positive
PCR result does not always
correlate with the presence 
of clinical haemoplasmal 
disease. This must be con -
sidered when interpreting
haemoplasma PCR results.
What are the
recommended
treatment approaches?
Antibiotics
Tetracycline and fluoroquinolone
antibiotics are effective at reducing
haemoplasma organism numbers in the
blood, although consistent predictable elimi-
nation of haemoplasma infection has not been
shown in any study.5,24,29,35,40,41 However,
antibiotics usually do improve clinical signs
and haematological abnormalities associated
with haemoplasma infection, even if elimina-
tion of haemoplasma infection does not
always result.  
The box on page 376 discusses the choice of
antibiotics for feline haemoplasmosis, recom-
mended dosages, treatment considerations
and factors that may affect treatment efficacy. 
Supportive care
We have found that cats clinically ill with
haemoplasmosis are often profoundly dehy-
drated, so correction of this with intravenous
fluid therapy is important. The degree of
anaemia in haemoplasmosis cases may be
masked by the dehydration causing haemo-
concentration, so haematological parameters
must be monitored after correction of dehy-
dration. Encouraging food intake (eg, offering
tempting warmed food, hand feeding) is
important in inappetent cats. More aggressive
nutritional support may be required if anorex-
ia is prolonged but in our experience anorexia
is usually short-lived once appropriate treat-
ment for haemoplasmosis has been given.  
Although cats are often able to tolerate
anaemia quite well, if the anaemia is severe
(PCV <12%) and/or has developed acutely
and is accompanied by significant associated
clinical signs, a blood transfusion, or treat-
FIG 6 Graph showing blood
haemoplasma copy numbers
over time in an individual cat
infected with M haemofelis.
Marked fluctuations are
apparent, with several 
log-fold differences in copy
numbers apparent over the
course of a few days. 
In our experience, up to a
third of cats infected with 
M haemofelis show these
marked fluctuations in copy
numbers, which have been
interpreted as cycling of
haemoplasma organisms in
the blood. Graph adapted
from data collected for a
previously published study35
When to treat?
A couple of issues need to be considered when deciding if
haemoplasmosis treatment is appropriate in an individual case:
✜ First, given that asymptomatic carrier cats exist, it must be borne
in mind that the presence of infection is not always accompanied by
associated clinical signs; 
✜ Secondly, there is no known antibiotic treatment regimen that reliably
eliminates haemoplasma infection, so treatment may not result in
haemoplasma clearance, even though the clinical signs of anaemia will
usually improve. 
If haemoplasma infection is diagnosed in a cat showing clinical signs
then treatment should be instigated, ideally to clear infection but
certainly to induce a clinical response. Treatment is also indicated
in cases with concurrent infections or diseases that could
exacerbate the potential for disease due to haemoplasma
infection (eg, in an immunosuppressed FIV-infected cat).
In cases in which treatment is instigated, monitoring
can be performed so that treatment efficacy
can be assessed.
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anaemia cases, although it is unlicensed for
use in cats. It is a potent colloid so care with its
use must be taken, particularly in cases prone
to circulatory overload; for example, cats with
cardiac disease (occult hypertrophic cardio -
myopathy), renal disease or respiratory 
disease. We have used a dose of 5–10 ml/kg 
in cats, administered intravenously at a rate 
of 0.5–2 ml/kg/h. The degree of anaemia can
be monitored using haemoglobin values.  
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ment with an oxygen carrying haemoglobin
compound (eg, Oxyglobin; OPK Biotech) if a
blood donor or blood products are not 
available, may be required. If a blood transfu-
sion is given, this should only be performed
after blood typing (and cross-matching, as
advised by some) both the donor and recipi-
ent. Oxyglobin has a long shelf-life and is 
stable at room temperature, so can be easily
stocked by practices that deal with feline
Tetracyclines
Tetracyclines, such as oxytetracycline at a dosage of 22
mg/kg q8h PO,28 are usually effective in the treatment 
of haemoplasmosis. Doxycycline (10 mg/kg q24h PO) is
usually the preferred tetracycline for the treatment of feline
hemoplasmosis, with prolonged treatment courses (up to 8 weeks)
recommended to increase the chance of eliminating infection.41
Evidence exists for doxycycline efficacy against all three feline
haemoplasma species, although controlled studies have only been
performed for M haemofelis.40–42 Anecdotally, it has been reported
that some cats vomit when given doxycycline once daily at 10
mg/kg, and that twice daily dosing of 5 mg/kg is better tolerated.
Some doxycycline formulations have also been associated with
oesophagitis and oesophageal strictures in cats.43,44 Such side
effects are believed to be related to the high acidity of some doxy-
cycline preparations when dissolved (particularly the doxycycline
hydrate form, used in a commercial tablet preparation in the UK),
which induces irritation of the oesophageal and gastric mucosa.
Such doxycycline dosing must therefore always be followed by a
small amount of food or syringing of water to encourage complete
swallowing of tablets into the stomach. Other formulations, such
as doxycycline monohydrate, are far less acidic and take longer 
to dissolve in the neutral environment of the oesophagus, and so
are associated with fewer side effects. Doxycycline monohydrate
solutions are licensed for use in cats in various countries including
Australia, New Zealand and South Africa.
Fluoroquinolones
Fluoroquinolones are also often an effective treatment for haemo-
plasmosis. Enrofloxacin (5 mg/kg q24h PO) has been successfully
used to treat M haemofelis infection in controlled studies. However,
diffuse retinal degeneration and acute blindness have been report-
ed following enrofloxacin treatment in cats. Although this is said to
be rare, great caution must be exercised with its use in
cats, and other fluoroquinolones should be used in pref-
erence whenever possible. Marbofloxacin has also been
effective at reducing M haemofelis and ‘Candidatus M
haemominutum’ organism numbers in the blood of treated
cats in controlled studies, using the recommended UK dosage of 
2 mg/kg q24h PO, although the fall in ‘Candidatus M haemominu-
tum’ organism numbers was less pronounced than that of M
haemofelis.5,35 A study using marbofloxacin at the recommended
US dose of 2.75 mg/kg q24h PO found evidence of improved
haematological parameters in treated M haemofelis-infected cats
compared with untreated controls.45 To the author’s knowledge, no
reports of ocular abnormalities in cats following marbo floxacin
treatment have been published, and the US study included regular
fundic examinations of marbofloxacin-treated cats and found no
evidence of adverse effects.45 The efficacy of 14 days of prado -
floxacin treatment of experimental M haemofelis infection has
recently been reported,42 where it was found to be effective (at 
the standard 5 mg/kg q24h PO dose, as well as a higher dose of 
10 mg/kg q24h PO) at improving clinical signs and haematological
values, and lowering M haemofelis copy numbers in the blood.
Imidocarb
Although imidocarb dipropionate has been efficacious in some
field haemoplasma cases, a controlled study failed to show any
beneficial effect of this antiprotozoal agent on clinical signs or
haematological values in M haemofelis-infected cats.46,47 However,
it may be worth considering imidocarb treatment in chronic haemo-
plasma cases that appear to be refractory to tetracyclines and/or
fluoroquinolones, as some cases have shown a clinical improve-
ment with treatment. Recommended dosages are 5 mg/kg IM
every 2 weeks for two to four injections. The injectable nature of
this drug may be an advantage for some owners.
Which ant ibiot ic?
Factors affecting haemoplasmosis antibiotic efficacy
It is possible that different isolates, as well as different haemoplasma species, respond to antibiotic treatments different-
ly. Other factors may contribute to antibiotic resistance. A recent study found that one isolate of the porcine haemoplas-
ma Mycoplasma suis was able to penetrate porcine erythrocytes and that its intracellular location was associated with
marked resistance to antibiotic therapy.48 Additionally the route of administration of antibiotics may play a role in the effi-
cacy of treatment, and this should be investigated in the future. It may be that, for example, initial intravenous anti biotic
administration is advantageous for the treatment of acute haemoplasmosis, to increase and/or hasten maximal anti -
biotic blood levels. In our experience, although antibiotics may not always induce infection clearance, a clinical response
to antibiotics is usually seen. However, some cases do appear to be clinically refractory to standard anti biotic treatments.
Occasionally dual therapy (typically doxycycline and marbofloxacin) has been tried, with variable success, but it may be
worth considering introducing an additional agent if monotherapy with doxycycline or a fluoro quinolone is inadequate.
The use of corticosteroids might also be considered in refractory cases with severe immune-mediated haemolysis 
(see corticosteroids section, page 377), although we have very rarely needed to use them in this context.
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Corticosteroids
It has been reported that the
anaemia induced by haemoplas-
ma infection is in part immune-
mediated and so cortico -
steroids have been recom-
mended as adjunct 
therapy.49 However, the
value of corticosteroids in
the treatment of haemo-
plasmosis has not been
proven and, as men-
tioned earlier, anaemic
Coombs’-positive cats
infected with M haemofelis
respond to antibiotic treat-
ment alone,3,50 which calls
into question the need for
immunosuppressive treatment.
Indeed in some cases concurrent
corticosteroid therapy has been asso-
ciated with a delay in obtaining apparent
haemoplasma clearance from the blood. It has
been shown that a ‘Candidatus M turicensis’
infected cat that received methylprednisolone
acetate prior to infection developed a more
severe anaemia than an immunocompetent cat,9
so corticosteroids have the potential to exacer-
bate disease too.
We would recommended only considering
corticosteroid treatment in cases that are 
deteriorating despite administration of an
appropriate antibiotic and in which immune-
mediated haemolytic anaemia (IMHA) is
thought to be a major component of the 
disease, or in cases in which haemoplasma
infection is not strongly believed to be the
underlying cause of disease.
How is the treatment response
monitored?
Since the haemoplasmas have not been
grown in vitro to date, qPCR offers a
reliable alternative means of assess-
ing the response to anti biotics. Cats
can become PCR negative during
anti biotic treatment (but it may
take a number of days or even
weeks for the haemoplasma levels
to fall to below detection limits),5,35
and may become PCR positive
again when antibiotic treatment is
stopped.50 Ideally blood sampling
for PCR should precede the start of
antibiotic treatment, although a posi-
tive result with high organism numbers
would indicate that the therapy is not
being optimally effective.  
Blood sampling for qPCR should be repeat-
ed a week or two after starting antibiotic ther-
apy to ensure therapy is effective at lowering
haemoplasma copy numbers. If efficacy is
seen, therapy should be continued for up to 8
weeks, ideally with documentation of negative
PCR results at completion of treatment. A goal
of any treatment protocol for haemoplasmosis
should be to eliminate infection, although
proving infection has been eliminated is diffi-
cult without performing PCR on the whole
host! Repeatedly negative results on blood
samples tested with a sensitive PCR assay
(monthly is suggested, two to three times) are
probably most reliable to indicate elimination.
If negative results do not result from treatment
(ie, elimination is not possible), control of 
clinical signs and a reduction in copy numbers
in the blood nevertheless indicates treatment
efficacy. However, recrudescence of disease
remains possible as long as these cases remain
haemoplasma positive.
✜ Interpret PCR results in the light of the patient’s clinical signs,
haematological parameters, the haemoplasma species detected,
and the amount of haemoplasma DNA present in the blood as
determined by qPCR.
✜ A positive PCR result does not equate with the haemoplasma
being the cause of the cat’s clinical signs; a PCR assay 
detects infection rather than confirming the cause of the cat’s
anaemia.
✜ Be aware that M haemofelis organism loads in the blood of
some cats can spontaneously fluctuate quite markedly, with
increases and decreases occurring quickly over the course of 
a day or two. Hence, do not always assume decreases are
indicative of effective antibiotic therapy or spontaneous
elimination of the organism.
✜ Asymptomatic carrier cats exist for all haemoplasma 
species but this status seems to be especially long term 
with ‘Candidatus M haemominutum’.
✜ Samples for PCR should ideally be collected before antibiotic
treatment is started, although documentation of a high blood
organism load during treatment may be useful in indicating
treatment failure.
✜ Elimination of infection is very difficult to prove but
repeatedly negative PCR results (monthly is suggested, two to
three times) on blood samples are supportive of elimination.
✜ Discordant results (ie, positive and negative results on the
same sample) can occur if the number of haemoplasma
organisms in the blood is very low and close to the sensitivity
detection limit of the PCR assay. This is because when such low
haemoplasma levels are present, the aliquot of sample used in
the PCR may not contain the single copy of haemoplasma DNA
that allows successful amplification and the subsequent positive
PCR result.
Considerat ions in interpret ing PCR results
Are haemoplasmas zoonotic?
Previous reports have documented haemoplasmosis in
humans using cytology, although our attempts to successfully
amplify haemoplasma DNA from samples recruited from some of
these studies have failed (unpublished observations), suggesting that
previous reports of human haemoplasmosis based solely on cytological
diagnosis should be viewed with caution. More recently, however, PCR
has been used to show evidence of haemoplasma infection in humans.
PCR has documented the presence of an organism very similar to M suis
in people in China, although clinical haemoplasmosis was not com-
mon.51,52  In another study, a M haemofelis-like organism was detected
in an immunosuppressed HIV-positive patient who had concurrent
bartonellosis and a history of cat scratches.53 However, the con-
tribution of the M haemofelis-like infection to the man’s clinical
signs was not discussed. These reports certainly suggest
the existence of zoonotic haemoplasma infections,
which will need to be further investigated to
clearly define the epidemiology of
human haemoplasmosis.
A goal of any treatment protocol for
haemoplasmosis should be to eliminate infection.
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C a s e  n o t e s
A 2-year-old male domestic shorthair cat presented with
a 1 week history of progressive lethargy and anorexia. 
He was fully vaccinated and wormed and had access
outdoors. On clinical examination he was slightly dull
and had pale mucous membranes. He was tachycardic
(heart rate 220 beats per minute) with a left-sided grade
II/VI systolic heart murmur, tachypnoeic (respiratory rate
60 breaths per minute) and pyrexic (39.6°C/103.4°F).
Abdominal palpation was unremarkable but skin tenting
was evident, indicating dehydration.
Initial diagnostic testing and management 
✜ Blood smear examination A freshly collected blood sample
was rapidly dried and stained with Diff-Quik. Microscopy examination
revealed variation in
erythrocyte size
(anisocytosis),
bluish colouring 
to some of the
erythrocytes
(polychromasia),
the presence of
some nucleated
erythrocytes and
agglutination of
erythrocytes.
Additionally small
blue cellular bodies
were seen on the
surface of some
erythrocytes. Platelets were present in adequate numbers.
✜ PCV An in-house estimation performed using a small sample 
of EDTA anticoagulated blood revealed a PCV of 16% (reference
range 25–45%), consistent with moderate anaemia.  
To correct the dehydration present, the cat was immediately
given intravenous fluid therapy (2 ml/kg/h maintenance
requirement + 4 ml/kg/h to correct the estimated 10% dehydration
for 24 h [total 6 ml/kg/h] of lactated Ringer’s solution, an isotonic
replacement fluid). He was placed in a quiet area of the hospital
and regularly monitored while other diagnostics were performed 
to elucidate the cause of his anaemia.
✜ Slide agglutination test Four drops of normal (0.9%) saline
and one drop of whole EDTA blood were placed on a microscope
slide, which was gently rocked to encourage mixing. Within a few
minutes distinct red speckles had developed, consistent with gross
macroscopic agglutination (sticking together of red blood cells in
disorganised clumps) due to the presence of warm agglutinating
erythrocyte-bound antibodies. The agglutination was confirmed by
examination of the slide
under the microscope after
adding a cover slip. 
The saline in the slide
agglutination test should
disperse any rouleaux
formation (organised
stacking of overlapping red
blood cells in columns) in
the cat, which grossly 
can mimic agglutination.
Some recommend using 
up to 10 drops of saline to one drop of blood in the slide
agglutination test, but a ratio of 1:4 is usually adequate.
Major differential diagnoses to consider 
in an anaemic cat 
✜ Regenerative anaemia due to blood loss
Acute blood loss will result in anaemia but hypovolaemic shock 
is usually the initial concern:
– Trauma (eg, road traffic accident);
– Coagulopathy (liver disease, rodenticide toxicity, haemophilia);
– Thrombocytopenia;
– Systemic amyloidosis can result in spontaneous hepatic rupture
and acute abdominal haemorrhage in young to middle-aged
cats. Siamese and related cats appear to be predisposed;  
– Gastroduodenal ulceration and bleeding can arise due to
neoplasia (mast cell tumours, gastrinoma, lymphoma), 
NSAID toxicity or inflammatory bowel disease;
– ‘Menrath’ ulcers (ie, bleeding lesions in the mouth of cats
associated with erosion of palatine vessels).
Chronic blood loss is occasionally seen in cats:
– Severe ectoparasitism (fleas and lice) in kittens;
– Gastroduodenal ulceration and bleeding with a more chronic course
due to neoplasia, NSAID toxicity or inflammatory bowel disease;
– Systemic amyloidosis can also result in a more chronic course 
of intermittent hepatic bleeding;
– Chronic bleeding from the urinary tract due to neoplasia or
severe prolonged inflammation.
✜ Regenerative anaemia due to haemolysis
– Primary IMHA (recent reports suggest it is more common than
previously believed); 
– IMHA secondary to infectious agents such as FeLV,
haemoplasmas and feline infectious peritonitis (FIP) virus, 
drugs (eg, methimazole, trimethoprim-sulphonamides),
neoplasia (eg, lymphoma, myeloproliferative disorders) and
haemolytic blood transfusion reactions;
– Infections causing haemolysis (FeLV infection, haemoplasmosis,
Babesia species, cytauxzoonosis, FIV infection);
– Oxidant injury causing Heinz body haemolytic anaemia (due to
exposure to chemicals or toxins [onions] and some disease
states [diabetic ketoacidosis, hyperthyroidism, lymphoma]);
– Hypophosphataemia (<0.35 mmol/l) can result in haemolysis 
and has been associated with diseases such as diabetes
mellitus and hepatic lipidosis;
– Inherited red blood cell defects such as osmotic fragility and
pyruvate kinase deficiency in Abyssinians and Somalis;
– Microangiopathic haemolytic anaemia due to damage to the
vascular endothelium. 
✜ Non-regenerative anaemia
Primary bone marrow disorders often result in
moderate to severe anaemia:
– Pure red cell aplasia;
– Aplastic anaemia;
– Myelodysplastic syndromes;
– Myelophthisis;
– Myeloproliferative diseases.
Positive slide agglutination test. The red speckles in the sample of
saline and blood on the left indicate the presence of erythrocyte-
bound antibodies. A negative control on the right is shown for
comparison
Blood smear showing polychromasia, anisocytosis and
the presence of small blue cellular bodies on the surface
of some erythrocytes
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Systemic causes of bone marrow suppression are often associated
with milder anaemia:
– Anaemia of inflammatory (chronic) disease (very common in cats);
– Chronic renal failure;
– FeLV- or FIV-associated non-regenerative anaemia.
Further laboratory assessment
In this case, evidence for regeneration (polychromasia and
anisocytosis) was seen on the blood smear, pointing to haemolysis
or blood loss as being the most likely cause, although confirmation
of the regenerative nature of the anaemia (as well as the degree of
regeneration) required enumeration of reticulocytes. No evidence 
of blood loss was present, and the positive slide agglutination test
indicated the presence of erythrocyte-bound antibodies in the cat,
suggesting IMHA to be present. The cat had not been given any
medications before presentation. The presence of small blue cellular
bodies on the surface of some erythrocytes made haemoplasmosis
a major differential diagnosis. The pyrexia at presentation was also
consistent with haemoplasmosis.
In view of these findings the cat was immediately given oral
doxycycline, followed by syringed water to ensure complete
swallowing of the tablet, and the response to
treatment was monitored.
Routine haematology, performed a few
hours after the start of intravenous fluid
therapy, indicated the presence of a severe
macrocytic anaemia and evidence of 
a degenerative neutrophilic left shift 
(see table). The macrocytosis was
excessive and, although this could reflect
regeneration, other possible causes of
macrocytosis include agglutination of red
blood cells precluding accurate estimation
of red blood cell size, a myelodysplastic
syndrome or FeLV infection (the latter two
causes usually being non-regenerative).
The haematocrit was lower than the PCV
measured previously, possibly due to
partial correction of dehydration as a result
of fluid therapy.  
A serum biochemistry profile revealed
markedly elevated ALT (672 iu/l; reference
range 15–60), mildly elevated bilirubin (25
μmol/l; reference range <10), and a normal
serum protein concentration. No other
significant abnormalities were found. The elevated ALT was
thought to reflect hepatic hypoxia as a result of the anaemia while
hyperbilirubinaemia was consistent with ongoing haemolysis.  
In-house FeLV and FIV ELISAs were negative.
A reticulocyte count was also requested and revealed 380 x 109/l
aggregate reticulocytes, consistent with substantial regeneration.
Blood was submitted for haemoplasma PCR testing but results
were not immediately available.
Presumptive diagnosis and treatment
At this stage a diagnosis of IMHA was made, believed to be
secondary to haemoplasma infection. 
Doxycycline treatment for potential haemoplasma infection 
had already been started and was continued while the patient’s
response to therapy was assessed. Immediate treatment with
corticosteroids was considered, due to the diagnosis of IMHA, 
but was withheld as the patient did not deteriorate, and responded
well (within 24 h) to initial treatment with antibiotics and fluid
therapy (as do most cases of acute haemoplasmosis). 
Had the patient not improved, and in the absence of confirmed
haemoplasmosis, trial treatment with 2 mg/kg/day of prednisolone
would have been justified in case the IMHA was primary 
in nature. 
A blood transfusion was not required in this case, primarily
because the cat’s clinical status was not severe enough to warrant
this, and his PCV remained above 13% and rose quickly following
treatment. If a blood transfusion had been required, blood typing 
of the donor and recipient, and/or cross-
matching, would have been necessary,
although this may have been difficult to
interpret due to the autoagglutination
present.
The patient was given tempting foods 
by hand and his PCV and hydration status
were monitored closely over the next few
days. His dehydration was corrected within
24 h and he began eating voluntarily,
enabling us to reduce and stop intravenous
fluid therapy within 3 days. His PCV rose
steadily after starting doxycycline therapy,
reaching 16% after 2 days of treatment 
and 19% after 4 days of treatment. 
The cat was discharged 5 days after
presentation, on continuing doxycycline
treatment. Flea treatment was also
recommended in view of fleas being
potential vectors of haemoplasmas.
PCR confirmation and monitoring
PCR analysis revealed the presence of large
numbers of M haemofelis in the blood,
confirming the diagnosis of M haemofelis-associated IMHA.
At a recheck, a week after presentation, the cat’s PCV was 23%. 
Repeat PCR analysis 2 weeks after starting doxycycline therapy
showed only low levels of M haemofelis in the blood. Therapy was
continued for a total of 8 weeks, after which a negative PCR result
was obtained.
Parameter Value Reference
range
Haemoglobin 4.4 g/dl 8–14
RBC 1.57 x 1012/l 5.5–10
Haematocrit 13 l/l 25–45
MCV 82.7 fl 39–55
MCHC 33.8 % 30–36
Total WBC 12.9 x 109/l 7–20
PMNs 6.45 x 109/l 2.5–12.8
Band PMNs 1.032 x 109/l 0.0–0.0
Lymphocytes 4.644 x 109/l 1.5–7.0
Monocytes 0.774 x 109/l 0.07–0.85
Eosinophils 0.0 x 109/l 0.0–1.0
Platelets 224* x 109/l 300–500
Abnormal values shown in bold
*NB platelet clumps visible on the smear
Haematology results
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✜ Three main feline haemoplasma species exist: Mycoplasma haemofelis, ‘Candidatus Mycoplasma
haemominutum’ and ‘Candidatus Mycoplasma turicensis’.
✜ M haemofelis is the most pathogenic species; ‘Candidatus M haemominutum’ and ‘Candidatus
M turicensis’ are less pathogenic, unless concurrent disease or immunosuppression is present. 
✜ ‘Candidatus M haemominutum’ infection is more common than ‘Candidatus M turicensis’ and M haemofelis
infections.
✜ Clinical signs include pallor, lethargy, anorexia, weight loss, depression, dehydration and pyrexia.  
✜ The natural route of feline haemoplasma transmission between cats has not been confirmed, but fleas are implicated.
✜ Asymptomatic haemoplasma carrier cats exist, so documentation of the presence of infection in an anaemic cat
does not necessarily mean that the infection is the cause of the cat’s anaemia.
✜ Reliable diagnosis is based on polymerase chain reaction (PCR) assays performed on blood samples.  
✜ Since PCR results are unlikely to be available immediately, trial treatment for haemoplasma-associated
haemolytic anaemia with antibiotics (tetracyclines or fluoroquinolones) is warranted in suspected cases. 
A rapid response (often within 24 h) to antibiotic treatment and other supportive care is usually seen in cases 
with haemoplasmosis. 
✜ Corticosteroids are not usually required for the treatment of haemoplasmosis. However, if the patient is
deteriorating despite starting antibiotic treatment, and/or has no other supportive evidence for haemoplasmosis
(pyrexia, history of outdoor access and/or fleas), and has erythrocyte-bound antibodies confirmed (positive slide
agglutination test or Coombs’ test), and there is no other obvious cause of haemolysis present, treatment for
primary immune-mediated haemolytic anaemia is warranted and prednisolone can be tried.
KEY POINTS
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